Keywords: UFH; unfractionated heparin; LMWH; low molecular weight heparin; APC; activated protein C; DVT; deep vein thrombosis; IU; international units; tPA; tissue plasminogen activator; Inhaled; Antithrombotic therapy; Thrombolytic therapy;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Hyaluronic acid hydrogel; Cardiac progenitor cell; Growth factor sequestration; Neovascularization; LMWH; UMWH; HMWH; TGFβ1;
Keywords: GAG; glycosaminoglycan; GlcA; d-glucuronic acid; GlcA2SO3; d-glucuronic acid 2-sulfate; GlcN; d-glucosamine; GlcNSO36SO3; d-glucosamine N,6-sulfated; IdoA; l-iduronic acid; IdoA2SO3; l-iduronic acid 2-sulfate; TSD; trisulfated disaccharide; AT; antithromb
Keywords: CTPA; CT pulmonary angiography; DKA; diabetic ketoacidosis; ECMO; extracorporeal membrane oxygenation; LMWH; low-molecular-weight heparin; LV; left ventricle; MI; myocardial infarction; PE; pulmonary embolism; PRES; posterior reversible encephalopathy syn
Keywords: BISTRO; Boehringer Ingelheim Studyin Thrombosis; LDUH; low-dose unfractionated heparin; LMWH; low-molecular-weight heparin; NOAC; non-vitamin K antagonist oral anticoagulant; OD; once daily; VKA; vitamin K antagonist;
Keywords: ACT; activated clotting time; AF; atrial fibrillation; CB; cryoballoon; CB-A; cryoballoon ablation Arctic Front Advance; CT; computed tomography; ECG; electrocardiography; LA; left atrium; LIPV; left inferior pulmonary vein; LMWH; low-molecular-weight hep
Keywords: ACCP; American College of Chest Physicians; LMWH; low molecular weight heparin; PE; pulmonary embolism; TP; thromboprophylaxis; VTE; venous thromboembolism; Contraindications; Hospitalized patients; Observational study; Risk factors; Thromboprophylaxis; V
Keywords: IV; intravenous; UFH; unfractionated heparin; LMWH; low-molecular-weight heparins; VTE; venous thromboembolism; ACS; acute coronary syndrome; CrCl; creatinine clearance; UCDMC; University of California, Davis Medical Center; ISTH; International Society on
Keywords: ICU; Intensive Care Unit; DVT; Deep Vein Thrombosis; LMWH; Low Molecular Weight Heparin; CUS; Compressive UltraSonography; GES; Graduated Elastic Stocking; ECMO; Extra Corporeal Membrane Oxygenation; SAPS II; Simplified Acute Physiology Score II; Intensiv
Keywords: Anti-FXa; anti-activated factor X (activity); aPTT; activated partial thromboplastin time; CTAD; citrate, theophylline, adenosine, dipyridamole; CV; coefficient of variation; ELISA; enzyme-linked immunosorbent assay; FV; (coagulation) factor V; INR; inter
Keywords: LMWH; DAD; AMAC derivatization; ESI–MS; Compositional analysis
Keywords: CI; confidence interval; DVT; deep vein thrombosis; FDA; Food and Drug Administration; LMWH; low-molecular weight heparin; NOAC; New oral anticoagulant; PE; pulmonary embolism; RR; relative risk; UFH; unfractionated heparin; VKA; vitamin K antagonist; VTE
Keywords: AC; Anticoagulant; ALL; Acute lymphoblastic leukemia; CSF; Cerebrospinal fluid; GEE; Generalized estimating equations; LMWH; Low molecular weight heparin; LP; Lumbar puncture; RBC; Red blood cells; UFH; Unfractionated heparin;
Keywords: AF; atrial fibrillation; ARR; absolute risk reduction; ASA; aspirin (acetylsalicylic acid); GP; general practitioner; ICH; intracranial hemorrhage; IE; ischemic event; INR; international normalized ratio; LMWH; low-molecular-weight heparin; NACs; Network
Keywords: CAM; chick chorioallantoic membrane; LMWH; low molecular weight heparin; S-NACH; sulfated non-anticoagulant heparin; THBS1; Thrombospondin-1; XIAP; X-linked inhibitor of apoptosis protein; Low molecular weight heparin; Pancreatic cancer; Non-anticoagulant
Keywords: Anticoagulation; Central nervous system; Complication; Hemorrhage; Optimization; Outcome; Stroke; Thrombosis; AC; Anticoagulation, anticoagulant; CNS; Central nervous system; GOS; Glasgow outcome scale; ICH; Intracerebral hemorrhage; LMWH; Low molecular w
Keywords: ADP; adenosine diphosphate; auto-PBSCT; autologous peripheral blood stem cell transplantation; LMWH; low molecular weight heparin; MPV; mean platelet volume; MM; multiple myeloma; NF-Îβ; nuclear factor-Îβ; VTE; venous thromboembolism; Multiple myeloma
Keywords: AF; atrial fibrillation; CS; coronary sinus; IQR; interquartile range; LAT; left atrial tachycardia; LMWH; low-molecular-weight heparin; MI; mitral isthmus; PMF; perimitral flutter; PV; pulmonary vein; PVI; pulmonary vein isolation; RF; radiofrequency; TT
Keywords: CVC; Central venous catheters; CRT; Central venous catheters related thrombosis; AML; acute myeloid leukemia; LMWH; low molecular weight heparin; PLT; platelet; PE; pulmonary embolism; DVT; deep vein thrombosis; VTE; venous thromboembolism; SVC; non-tunne
Keywords: VTE; VenousTthromboembolism; RIETE; Registro Informatizado de Enfermedad tromboEmbolica; LMWH; Low Molecular Weight Heparin; DVT; Deep Vein Thrombosis; PE; Pulmonary Embolism; VKA; Vitamin K Antagonists; ROC; Receiver Operating Characteristics; Anticoagul
Keywords: ACCP; American College of Chest Physicians; CI; Confidence Interval; CTPA; CT Pulmonary Angiogram; DVT; Deep vein thrombus; EBM; Evidence Based Medicine; ICH; Intracranial Hemorrhage; LMWH; Low Molecular Weight Heparin; NT-proBNP; N-terminal Pro-hormone o
Keywords: DVT; Deep vein thrombosis; LMWH; Low molecular weight heparins; K; Kirschner; VEGF; Vascular endothelial growth factor; IGFs; Insulin-like growth factors; Deep vein thrombosis; Fondaparinux; Fracture healing; Heparin; Low molecular weight heparin; Thrombo
Keywords: THA; total hip arthroplasty; VTE; venous thromboembolism; DVT; deep vein thrombosis; PE; pulmonary embolism; LMWH; low-molecular-weight heparin; VKA; vitamin K antagonist; AAOS; American Academy of Orthopaedic Surgeons; ACCP; American College of Chest Phy
Keywords: fVII; factor VII; fVIIa; activated factor VII; fXa; activated factor X; HNSCC; head and neck squamous cell carcinoma; LMWH; low molecular weight heparin; MM; multiple myeloma; MP; microparticles; PCA; procoagulant activity; PE; phosphatidylethanolamine; P
Keywords: ABC; Activity Based Costing; aPTT; activated Partial Thromboplastin Time; BMI; Body Mass Index; CT; computerized tomography; C-US; compression ultrasonography; DVT; deep vein thrombosis; ECG; electrocardiogram; INR; International Normalized Ratio; LMWH; l
Keywords: PT; prothrombin time; aPTT; activated partial thromboplastin time; PVT; portal vein thrombosis; LMWH; low molecular weight heparin; DVT; deep vein thrombosis; VKA; vitamin K antagonists; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steato
Keywords: tPA; Tissue Plasminogen Activator; HSA; Human Serum Albumin; FRET; Förster Resonance Energy Transfer; ADEPT; Antibody Directed Enzyme-linked Targeted Prodrug; PEG; PolyEthylene Glocol; PA; Plasminogen Activator; LMWH; Low Molecular Weight Heparin; HSA-Pr
Keywords: AIS; Arterial ischemic stroke; ASA; Aspirin; BBB; Blood-brain barrier; CBF; Cerebral blood flow; CNS; Central nervous system; CT; Computed tomography; IAT; Intra-arterial thrombolysis; IVT; Intravenous thrombolysis; LMWH; Low molecular-weight heparin; MCA
Keywords: GAG; glycosaminoglycan; FG; fucosylated glycosaminoglycan; DFG; depolymerized fucosylated glycosaminoglycan; UFH; unfractionated heparin; LMWH; low-molecular-weight heparin; DD; deacetylation degree; GalNAc4S6S; 4,6-O-disulfated N-acetylgalactosamine; Glc
Keywords: anetoderma; antiphospholipid antibody syndrome; chronic venous ulcer; hemostasis; hypercoagulable states; livedo reticularis; livedo vasculopathy; purpura; superficial venous thrombosis; thrombosis; APC; activated protein C; APLA; antiphospholipid antibod
Keywords: heparin; platelet-activating antibodies; thrombocytopenia; thrombosis; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-induced thrombocytopenia; LMWH; low-molecular-weight heparin; OD; optical density; PF4; platelet factor 4; SRA; serotonin-release
Asymptomatic damage of central nervous system defined by excess level of protein S100B by patients undergoing the radiofrequency ablation of ventricular tachycardia
Keywords: AF; atrial fibrillation; CAD; coronary artery disease; CNS; central nervous system; CT; computer tomography; DCM; dilated cardiomyopathy; EF; eject fiction; ICD; implantable cardioverter defibrillator; LA; left atrial; LMWH; low molecular weight heparin;
The effect on thrombin generation and anti-Xa levels of thromboprophylaxis dose adjustment in post-cesarean obese patients - A prospective cohort study
Keywords: EBL; estimated blood loss; eGFR; estimated glomerular filtration rate; ETP; endogenous thrombotic potential; BMI; body mass index; LMWH; low-molecular weight heparin; VTE; venous thromboembolism; Postpartum thromboprophylaxis; Obesity; Dose adjustment; Lo
Bedside implantation of a new temporary vena cava inferior filter - Safety and efficacy results of the European ANGEL-Registry
Keywords: CTA; computed-tomography angiography; cCT; cranial computer tomography; DVT; deep vein thrombosis; ICU; intensive care unit; IVCF; inferior vena cava filters; LMWH; low molecular weight heparin; PE; Pulmonary embolism; TP; thrombosis prophylaxis; UH; unfr
Novel heparin mimetics reveal cooperativity between exosite 2 and sodium-binding site of thrombin
Keywords: LMWH; low molecular weight heparin; LMWL; low molecular weight lignin; PEG; polyethylene glycol; UFH; unfractionated heparin; Allosteric inhibition; Exosites; Heparin; Heparin mimetics; Thrombin;
Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location
Keywords: DOAC; direct oral anticoagulant; DVT; deep vein thrombosis; LMWH; low-molecular-weight heparin; PE; pulmonary embolism; VKA; vitamin K antagonist; VTE; venous thromboembolism; VTE-AL; venous thromboembolism of atypical location; VTE-TL; venous thromboembo
Takotsubo syndrome
Keywords: ACS; acute coronary syndrome; ECG; electrocardiography; ECHO; echocardiography; EF; ejection fraction; ECMO; extra-corporeal membrane oxygenator; HPA; hypothalamus pituitary axis; IABP; intra-aortic balloon pump; LVAD; Left ventricle assist device; LMWH;
The Evolving Face of Myocardial Reperfusion in Acute Coronary Syndromes: A Primer for the Internist
Keywords: ACS; acute coronary syndrome; ACT; activated clotting time; ADP; adenosine diphosphate; AHA/ACC; American Heart Association American/College of Cardiology; APTT; activated partial thromboplastin time; AVM; arteriovenous malformation; BID; twice daily; CAB
Antithrombin III-Binding Site Analysis of Low-Molecular-Weight Heparin Fractions
Keywords: heparin; LMWH; gel permeation chromatography; compositional analysis; LC-MS; SPR;
Solubility-enhanced gMYL6 fused with a hexa-lysine tag promotes the cytotoxicity of human NK cells
Keywords: gMYL6; goat myosin light chain 6; ACBPs; anti-cancer bioactive peptides; NK; natural killer; UCB; umbilical cord blood; HSCs; hematopoietic stem cells; gPRDX5; goat peroxiredoxin-5; BabA; blood group antigen-binding adhesion; Amp; ampicillin; IPTG; iso-pr
Comparative Effectiveness of Enoxaparin vs Dalteparin for Thromboprophylaxis After Traumatic Injury
Keywords: comparative effectiveness; dalteparin; enoxaparin; prophylaxis; trauma; VTE; DID; difference-in-differences; LMWH; low-molecular-weight heparin; PE; pulmonary embolism; PTSF; Pennsylvania Trauma System Foundation; RR; rate ratio; SDF; standardized differe
Structural analysis and biological activity of a highly regular glycosaminoglycan from Achatina fulica
Keywords: GAG; glycosaminoglycan; LMWH; low-molecular-weight heparin; DS; dermatan sulfate; TSP; trimethylsilyl-propionic acid; GlcA; glucuronic acid; GlcNAc; N-acetyl-2-deoxy-2-amino-glucose; IdoA; iduronic acid; IdoA2S; 2-sulfated iduronic acid; Mw; molecular wei
Evidence of a role for spinal HMGB1 in ischemic stress-induced mechanical allodynia in mice
Keywords: CPSP; central post-stroke pain; HMGB1; high-mobility group box-1; BCAO; bilateral carotid artery occlusion; mAb; monoclonal antibody; LMWH; low-molecular-weight heparin; LPS-RS; lipopolysaccharides from the photosynthetic bacterium Rhodobacter sphaeroides
Case ReportWarfarin associated venous limb gangrene in cancer-related DVT (case report)
Keywords: DVT; deep vein thrombosis; LMWH; low molecular weight heparin; LET; lower extremity thrombosis (Classification); NSAID; non steroidal anti-inflammatory drug; INR; international normalized ratio; FFP; fresh frozen plasma; VKA; vitamin K antagonists; ICU; i
PAPERSAnticoagulants to prevent recurrent placenta-mediated pregnancy complications: Is it time to put the needles away?
Keywords: Low-molecular-weight heparin; Pre-eclampsia; Placental abruption; Pregnancy loss; Small-for-gestational age; Thrombophilia; LMWH; low-molecular-weight heparin; SGA; small-for-gestational age; FVL; Factor V Leiden; PGM; prothrombin gene mutation; ASA; aspi
Implementation of a rapid HIT immunoassay at a university hospital - Retrospective analysis of HIT laboratory orders in patients with thrombocytopenia
Keywords: CLIA; chemiluminescent immunoassay; DTI; direct thrombin inhibitor; EDTA; ethylenediaminetetraacetic acid; ELISA; enzyme-linked immunosorbent assay; HIPA; heparin-induced platelet activation; HIT; heparin-induced thrombocytopenia; ICU; intensive care unit
Review ArticleExtended non-vitamin K antagonist oral anticoagulation therapy for prevention of recurrent venous thromboembolism
Keywords: ACCP; American College of Chest Physicians; Bid; twice daily; CI; confidence interval; DVT; deep-vein thrombosis; ESC; European Society of Cardiology; LMWH; low-molecular-weight heparin; NICE; National Institute for Health and Care Excellence; NOAC; non-v
“Bringing on the light” in a complex clinical scenario: Optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry)
Keywords: OCT; optical coherence tomography; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; LMWH; low molecular weight heparin; NSTEMI; non ST-segment elevation myocardial infarction; PROTECT-OCT; Prospective Registry of Cancer Patients with Coronary Ste
Parent heparin and daughter LMW heparin correlation analysis using LC-MS and NMR
Keywords: Low molecular weight heparin; Parent heparin; Liquid chromatography mass spectrometry; Nuclear magnetic resonance; Correlation; LMWH; Low Molecular Weight Heparin; OSCS; Over-sulfated chondroitin sulfate; USP; United States Pharmacopeia; PNNL; Pacific Nor
Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves
Keywords: fetal risk; maternal risk; pregnancy; CI; confidence interval; LMWH; low-molecular-weight heparin; MHV; mechanical heart valve; RAR; ratio of averaged risk; UFH; unfractionated heparin; VKA; vitamin K antagonist;